Company intelligence / Profile preview

Apothekernes

Oslo, Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Apothekernes Laboratorium (A.L.) was a prominent Norwegian pharmaceutical company founded in 1903 by a group of pharmacists to ensure the supply of medicines. The company became globally recognized for its production of antibiotics, particularly bacitracin, and expanded significantly into the international market. In 1994, it merged with its U.S. subsidiary to form A.L. Pharma, which was later renamed Alpharma in 1995. Alpharma eventually became a major global player in specialty pharmaceuticals and animal health before being acquired by King Pharmaceuticals in 2008, which was subsequently acquired by Pfizer.

Therapeutic areas: NeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Pharma

Beyond the preview

Go deeper on Apothekernes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apothekernes.

Explore the full profile